{"count": 7, "results": [{"_id": "9591440", "pmid": 9591440, "title": "[Atenolol in the treatment of patients with airway obstruction].", "journal": "Pol Merkur Lekarski", "authors": ["Chazan R"], "date": "1998-02-01T00:00:00Z", "meta_date_publication": "1998 Feb", "meta_volume": "4", "meta_issue": "20", "meta_pages": "89-91", "score": 50089.926, "text_hl": "[@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ in the treatment of @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Airway_Obstruction</m> @DISEASE_MESH:D000402 @@@airway obstruction@@@].", "citations": {"NLM": "Chazan R. [Atenolol in the treatment of patients with airway obstruction]. Pol Merkur Lekarski. 1998 Feb;4(20):89-91. PMID: 9591440", "BibTeX": "@article{9591440, title={[Atenolol in the treatment of patients with airway obstruction].}, author={Chazan R}, journal={Pol Merkur Lekarski}, volume={4}, number={20}, pages={89-91}}"}}, {"_id": "9273241", "pmid": 9273241, "title": "[Atenolol in treatment of patients with airway obstruction].", "journal": "Pol Merkur Lekarski", "authors": ["Chazan R"], "date": "1996-12-01T00:00:00Z", "meta_date_publication": "1996 Dec", "meta_volume": "1", "meta_issue": "6", "meta_pages": "428-30", "score": 50089.21, "text_hl": "[@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ in treatment of @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Airway_Obstruction</m> @DISEASE_MESH:D000402 @@@airway obstruction@@@].", "citations": {"NLM": "Chazan R. [Atenolol in treatment of patients with airway obstruction]. Pol Merkur Lekarski. 1996 Dec;1(6):428-30. PMID: 9273241", "BibTeX": "@article{9273241, title={[Atenolol in treatment of patients with airway obstruction].}, author={Chazan R}, journal={Pol Merkur Lekarski}, volume={1}, number={6}, pages={428-30}}"}}, {"_id": "6126285", "pmid": 6126285, "title": "Labetalol, beta blockers, and acute deterioration of chronic airway obstruction.", "journal": "Clin Exp Hypertens A", "authors": ["Adam WR", "Meagher EJ", "Barter CE"], "date": "1982-01-01T00:00:00Z", "doi": "10.3109/10641968209060799", "meta_date_publication": "1982", "meta_volume": "4", "meta_issue": "8", "meta_pages": "1419-28", "score": 50068.14, "text_hl": "On these acute studies, the order of preference for beta blocking drugs in management of @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Airway_Obstruction</m> @DISEASE_MESH:D000402 @@@obstructive airways disease@@@, would be @CHEMICAL_Labetalol @CHEMICAL_MESH:D007741 @@@labetalol@@@, (@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@) or (metoprolol) and then @CHEMICAL_Propranolol @CHEMICAL_MESH:D011433 @@@propranolol@@@.", "citations": {"NLM": "Adam WR, Meagher EJ, Barter CE. Labetalol, beta blockers, and acute deterioration of chronic airway obstruction. Clin Exp Hypertens A. 1982;4(8):1419-28. PMID: 6126285", "BibTeX": "@article{6126285, title={Labetalol, beta blockers, and acute deterioration of chronic airway obstruction.}, author={Adam WR and Meagher EJ and Barter CE}, journal={Clin Exp Hypertens A}, volume={4}, number={8}, pages={1419-28}}"}}, {"_id": "6860529", "pmid": 6860529, "title": "Comparison of the effects of single doses of atenolol and labetalol on airways obstruction in patients with hypertension and asthma.", "journal": "Br J Clin Pharmacol", "authors": ["Jackson SH", "Beevers DG"], "date": "1983-05-01T00:00:00Z", "doi": "10.1111/j.1365-2125.1983.tb02089.x", "meta_date_publication": "1983 May", "meta_volume": "15", "meta_issue": "5", "meta_pages": "553-6", "score": 50062.418, "text_hl": "Comparison of the effects of single doses of @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ and @CHEMICAL_Labetalol @CHEMICAL_MESH:D007741 @@@labetalol@@@ on @<m>DISEASE_Airway_Obstruction</m> @DISEASE_MESH:D000402 @@@airways obstruction@@@ in @SPECIES_9606 @@@patients@@@ with @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ and @DISEASE_Asthma @DISEASE_MESH:D001249 @@@asthma@@@.", "citations": {"NLM": "Jackson SH, Beevers DG. Comparison of the effects of single doses of atenolol and labetalol on airways obstruction in patients with hypertension and asthma. Br J Clin Pharmacol. 1983 May;15(5):553-6. PMID: 6860529", "BibTeX": "@article{6860529, title={Comparison of the effects of single doses of atenolol and labetalol on airways obstruction in patients with hypertension and asthma.}, author={Jackson SH and Beevers DG}, journal={Br J Clin Pharmacol}, volume={15}, number={5}, pages={553-6}}"}}, {"_id": "2200257", "pmid": 2200257, "title": "Comparative evaluation of cardioselectivity of metoprolol OROS and atenolol: a double-blind, placebo-controlled crossover study.", "journal": "Am Heart J", "authors": ["Tantucci C", "Bruni B", "Dottorini ML", "Peccini F", "Motolese M", "Lecaillon JB", "Sorbini CA", "Grassi V"], "date": "1990-08-01T00:00:00Z", "doi": "10.1016/0002-8703(90)90106-8", "meta_date_publication": "1990 Aug", "meta_volume": "120", "meta_issue": "2", "meta_pages": "467-72", "score": 50060.016, "text_hl": "Cardioselectivity of a single oral dose of @CHEMICAL_Metoprolol @CHEMICAL_MESH:D008790 @@@metoprolol@@@ oral osmotic (OROS) (14/190 mg) and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ (100 mg) was compared in 12 @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Airway_Obstruction</m> @DISEASE_MESH:D000402 @@@reversible obstructive airway disease@@@ by assessing the dose-response curve to increasing doses of inhaled @CHEMICAL_Albuterol @CHEMICAL_MESH:D000420 @@@salbutamol@@@. ", "citations": {"NLM": "Tantucci C, Bruni B, Dottorini ML, Peccini F, Motolese M, Lecaillon JB, Sorbini CA, Grassi V. Comparative evaluation of cardioselectivity of metoprolol OROS and atenolol: a double-blind, placebo-controlled crossover study. Am Heart J. 1990 Aug;120(2):467-72. PMID: 2200257", "BibTeX": "@article{2200257, title={Comparative evaluation of cardioselectivity of metoprolol OROS and atenolol: a double-blind, placebo-controlled crossover study.}, author={Tantucci C and Bruni B and Dottorini ML and Peccini F and Motolese M and Lecaillon JB and Sorbini CA and Grassi V}, journal={Am Heart J}, volume={120}, number={2}, pages={467-72}}"}}, {"_id": "7916004", "pmid": 7916004, "title": "Osmotic release oral drug delivery system of metoprolol in hypertensive asthmatic patients. Pharmacodynamic effects on beta 2-adrenergic receptors.", "journal": "Hypertension", "authors": ["Bauer K", "Kaik G", "Kaik B"], "date": "1994-09-01T00:00:00Z", "doi": "10.1161/01.hyp.24.3.339", "meta_date_publication": "1994 Sep", "meta_volume": "24", "meta_issue": "3", "meta_pages": "339-46", "score": 50045.43, "text_hl": "The median cumulative @CHEMICAL_Albuterol @CHEMICAL_MESH:D000420 @@@salbutamol@@@ concentrations causing a 50% @<m>DISEASE_Airway_Obstruction</m> @DISEASE_MESH:D000402 @@@increase in specific airway conductance@@@ were 416 and 384 micrograms (days 1 and 7, respectively) for placebo, 594 and 444 micrograms for @CHEMICAL_Metoprolol @CHEMICAL_MESH:D008790 @@@metoprolol@@@, and 562 and 1419 micrograms for @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@. ", "citations": {"NLM": "Bauer K, Kaik G, Kaik B. Osmotic release oral drug delivery system of metoprolol in hypertensive asthmatic patients. Pharmacodynamic effects on beta 2-adrenergic receptors. Hypertension. 1994 Sep;24(3):339-46. PMID: 7916004", "BibTeX": "@article{7916004, title={Osmotic release oral drug delivery system of metoprolol in hypertensive asthmatic patients. Pharmacodynamic effects on beta 2-adrenergic receptors.}, author={Bauer K and Kaik G and Kaik B}, journal={Hypertension}, volume={24}, number={3}, pages={339-46}}"}}, {"_id": "2439820", "pmid": 2439820, "title": "Pharmacological characteristics of beta blockers and their role in clinical practice.", "journal": "J Cardiovasc Pharmacol", "authors": ["McDevitt DG"], "date": "1986-01-01T00:00:00Z", "doi": "10.1097/00005344-198608006-00002", "meta_date_publication": "1986", "meta_volume": "8 Suppl 6", "meta_issue": "", "meta_pages": "S5-11", "score": 50033.867, "text_hl": "Cardioselectivity refers to the ability of some drugs, notably @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ and @CHEMICAL_Metoprolol @CHEMICAL_MESH:D008790 @@@metoprolol@@@, to block beta 1 receptors without blocking beta 2 receptors. ", "citations": {"NLM": "McDevitt DG. Pharmacological characteristics of beta blockers and their role in clinical practice. J Cardiovasc Pharmacol. 1986;8 Suppl 6():S5-11. PMID: 2439820", "BibTeX": "@article{2439820, title={Pharmacological characteristics of beta blockers and their role in clinical practice.}, author={McDevitt DG}, journal={J Cardiovasc Pharmacol}, volume={8 Suppl 6}, pages={S5-11}}"}}]}